Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Derm Allergy/Immunology

Dupilumab treatment in patients with atopic dermatitis: A comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures

British Journal of Dermatology | Jun 15, 2021 Derm Allergy/Immunology

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

Journal of the European Academy of Dermatology and Venereology | Jun 09, 2021 Derm Allergy/Immunology

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

Journal of the American Academy of Dermatology | Jun 07, 2021 Derm Allergy/Immunology

Skin adverse events related to personal protective equipment: A systematic review and metanalysis

Journal of the European Academy of Dermatology and Venereology | Jun 07, 2021 Derm Allergy/Immunology

Incidence of venous thromboembolism in patients with dermatologist-diagnosed chronic inflammatory skin diseases

JAMA | Jun 01, 2021 Derm Allergy/Immunology

Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa

Cytokine | May 30, 2021 Derm Allergy/Immunology

Rituximab vs mycophenolate mofetil in patients with pemphigus vulgaris

New England Journal of Medicine | May 29, 2021 Derm Allergy/Immunology

Once-daily upadacitinib vs placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): Results from two replicate double-blind, randomised controlled phase 3 trials

The Lancet | May 29, 2021 Derm Allergy/Immunology

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): Results from a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet | May 29, 2021 Derm Allergy/Immunology

Association between topical calcineurin inhibitor use and risk of cancer

JAMA | May 28, 2021 Derm Allergy/Immunology

« Prev 1 … 10 11 12 13 14 … 57 Next »

Dupilumab treatment in patients with atopic dermatitis: A comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

Skin adverse events related to personal protective equipment: A systematic review and metanalysis

Incidence of venous thromboembolism in patients with dermatologist-diagnosed chronic inflammatory skin diseases

Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa

Rituximab vs mycophenolate mofetil in patients with pemphigus vulgaris

Once-daily upadacitinib vs placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): Results from two replicate double-blind, randomised controlled phase 3 trials

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): Results from a randomised, double-blind, placebo-controlled, phase 3 trial

Association between topical calcineurin inhibitor use and risk of cancer

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Dupilumab treatment in patients with atopic dermatitis: A comparative cohort study between the Netherlands and Japan shows a discrepancy in patient-reported outcome measures

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

Skin adverse events related to personal protective equipment: A systematic review and metanalysis

Incidence of venous thromboembolism in patients with dermatologist-diagnosed chronic inflammatory skin diseases

Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa

Rituximab vs mycophenolate mofetil in patients with pemphigus vulgaris

Once-daily upadacitinib vs placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): Results from two replicate double-blind, randomised controlled phase 3 trials

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): Results from a randomised, double-blind, placebo-controlled, phase 3 trial

Association between topical calcineurin inhibitor use and risk of cancer

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Select Specialty

Select Topic